4431-00-9
基本信息
金精三羧酸
AURINTRICARBOXYLIC ACID
LABOTEST-BB LT00080677
TIMTEC-BB SBB005410
1,4-cyclohexadiene-1-carboxylicacid,3-(bis(3-carboxy-4-hydroxyphenyl)methylen
5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-benzoicaci
aluminonfreeacid
e)-6-oxo-
5,5-(3-carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid)
aurinetricarboxylic acid
AURINTRICARBOXYLIC ACID FREE ACIDPRACTIC AL GRADE
Aurintricarboxylic Acid (Ata)
AURINTRICARBONIC ACID
Aurintricarboxylic acid, tech., 85%
1-Oxo-4-[bis(3-carboxy-4-hydroxyphenyl)methylene]-2,5-cyclohexadiene-2-carboxylic acid
5,5'-[(3-Carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis(2-hydroxybenzoic acid)
物理化学性质
| 外观性状 | 桔红色至棕红色粉末。熔点220-225℃（分解）。易溶于水，微溶于乙醇，不溶于丙酮。 |
| 熔点 | 300 °C(lit.) |
| 沸点 | 458.99°C (rough estimate) |
| 密度 | 1.3860 (rough estimate) |
| 折射率 | 1.6230 (estimate) |
| 储存条件 | +15C to +30C |
| 溶解度 | 1 M NH4OH: 10 mg/mL |
| 酸度系数(pKa) | 2.20±0.20(Predicted) |
| 形态 | powder |
| 形态 | 粉末 |
| 颜色 | dark red to brown |
| 颜色 | 暗红色至棕色 |
| 水溶解性 | Insoluble in water. |
| BRN | 2228904 |
| CAS 数据库 | 4431-00-9(CAS DataBase Reference) |
| EPA化学物质信息 | Benzoic acid, 5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-2-hydroxy- (4431-00-9) |
安全数据
| 危险性符号(GHS) |  GHS07 |
| 警示词 | 警告 |
| 危险性描述 | H315-H319-H335 |
| 防范说明 | P261-P280a-P304+P340-P305+P351+P338-P405-P501a |
| 危险品标志 | Xi |
| 危险类别码 | R36/37/38 |
| 安全说明 | S26-S36 |
| WGK Germany | 3 |
| RTECS号 | GU4790000 |
| TSCA | Yes |
应用领域
制备方法
金精三羧酸价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/01/25 | HY-122575 | 金精三羧酸 Aurintricarboxylic acid | 4431-00-9 | 100mg | 550元 |
| 2024/01/25 | HY-122575 | 金精三羧酸 Aurintricarboxylic acid | 4431-00-9 | 10mM * 1mLin DMSO | 610元 |
| 2024/01/16 | A15905 | 金精三羧酸 Aurintricarboxylic acid | 4431-00-9 | 5g | 643元 |
常见问题列表
|
Topoisomerase II
|
rP2X1R 8.6 nM (IC 50 ) |
rP2X3R 72.9 nM (IC 50 ) |
Apoptosis
|
miRNA 0.47 μM (IC 50 ) |
Aurintricarboxylic acid strongly inhibits rP2X1Rs and rP2X3Rs with IC
50
values of 8.6 nM and 72.9 nM, respectively, and more weakly inhibits P2X2/3Rs, P2X2Rs, P2X4Rs or P2X7Rs.
Aurintricarboxylic acid inhibition of ATP-induced currents is concentration dependent.
Aurintricarboxylic acid is a non-competitive antagonist of P2X3R.
Aurintricarboxylic acid can inhibit the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and vaccinia virus.
Aurintricarboxylic acid protects MDCK cells from infection with influenza A strains PR8, NY or N.
Aurintricarboxylic acid inhibits replication of influenza A and B viruses.
Aurintricarboxylic acid inhibits neuraminidase activities of influenza A and B viruses.
Aurintricarboxylic acid inhibits TWEAK-Fn14-mediated NF-κB activation.
Aurintricarboxylic acid (10 μM;0.5-2 hours) suppresses TWEAK-Fn14-mediated NF-κB, Akt, and Src phosphorylation in GBM cells.
Aurintricarboxylic acid blocks TWEAK-stimulated Rac1 activation and TRAF2 recruitment to Fn14 cytoplasmic domain in glioma cells.
Aurintricarboxylic acid represses TWEAK-stimulated glioma cell migration and invasion without causing cell cytotoxicity.
Aurintricarboxylic acid (Compound 8) cannot regulate loading of endogenous let-7 onto AGO2 inside cultured cells, whereas can inhibit RISC loading of exogenous siRNA.
Western Blot Analysis
| Cell Line: | T98G, A172, GBM44 glioma cells |
| Concentration: | 10 μM |
| Incubation Time: | 0.5 hour, 1 hour, 2 hours |
| Result: | Abrogated TWEAK activation of downstream signals including phosphorylation of the NF-κB family member p65, Akt, and Src in all three GBM cell lines. |